# OnCo record immunebro-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/immunebro-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "immunebro-therapeutics" ;
  schema:name "ImmuneBro Therapeutics"@en ;
  schema:alternateName "Immunebro Therapeutics, Inc."@en, "IMMUNEBRO THERAPEUTICS INC."@en ;
  schema:description "ImmuneBro Therapeutics in Chicago makes off-the-shelf immune cell treatments from healthy donors' T cells, combined with a T-cell engager, without gene editing. Its lead product, IBT1116, is being prepared for trials in B-cell cancers."@en ;
  schema:url <https://onco.cc/companies/immunebro-therapeutics/>, <https://www.immunebro.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.immunebro.com/>, <https://reporter.nih.gov/project-details/11314650> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-cell-therapy/>, <https://onco.cc/technologies/t-cell-engager/> ;
  onco:drugs <https://onco.cc/drugs/ibt1116/> .